Rejuvenate Biomed logo

Rejuvenate Biomed

ID: 7762145

Rejuvenate Biomed is a Belgian based biomedical company engaged in developing prescription drugs in healthy ageing. By applying the progress made in geroscience (biology of aging) we identify and develop (up to POC) safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.

1

Funding Rounds

$15.7m

Money raised

Recent Funding Rounds

Overview

Rejuvenate Biomed is a Belgian based biomedical company engaged in developing prescription drugs in healthy ageing. By applying the progress made in geroscience (biology of aging) we identify and develop (up to POC) safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding series

Funding Series Analysis

The company Rejuvenate Biomed has raised a total of $15.7m in funding over 1 rounds.

Key Insights:

  • Rejuvenate Biomed Series B round, October 2021: $15.7m

Industries

Rejuvenate Biomed is active in the following industries: